| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4002711 | American Journal of Ophthalmology | 2013 | 9 Pages |
Abstract
Intravitreal bevacizumab is an effective therapy for complicated RAM, quickly improving BCVA and CRT. Anti-vascular endothelial growth factor (VEGF) drugs might actively close the involved pathologically permeabilized retinal artery and normalize the vessel wall formation by localized inhibition of VEGF.
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Francesco Pichi, Mariachiara Morara, Carlo Torrazza, Gianluigi Manzi, Micol Alkabes, Nicole Balducci, Lucia Vitale, Andrea Lembo, Antonio P. Ciardella, Paolo Nucci,